Sino Biopharmaceutical Limited (HKG:1177)

Sino Biopharmaceutical Revenue

Sino Biopharmaceutical had revenue of 19.44B CNY in the half year ending June 30, 2026, with 22.49% growth. This brings the company's total for the last twelve months to 33.70B, up 10.26% year-over-year. In the year 2025, Sino Biopharmaceutical had annual revenue of 31.83B with 10.28% growth. That makes Sino Biopharmaceutical the 2,661st largest company in the world by revenue and 175th in Hong Kong.

• Revenue (ttm): 33.70B CNY
• Revenue Growth: +10.26%
• P/S Ratio: 2.54
• Revenue / Employee: 1.48M CNY
• Employees: 22,838
• Market Cap: 98.58B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	31.83B	2.97B	10.28%
Dec 31, 2024	28.87B	2.67B	10.18%
Dec 31, 2023	26.20B	173.25M	0.67%
Dec 31, 2022	26.03B	-835.19M	-3.11%
Dec 31, 2021	26.86B	3.21B	13.59%

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 6, 2026

Data Sources Report a data error